By Kenneth Rapoza, CPA Industry Analyst Votes are not all in yet, but we can confirm that there will be a changing of the guard...

By Kenneth Rapoza, CPA Industry Analyst As the trade deficit rises on the backs of some economic improvements, one thing stands out: a reduction in...

By Kenneth Rapoza, CPA Industry Analyst CPA Member Nexus Pharmaceuticals adds 12th FDA approval to its roster of medicines. We think the new list of...

By Kenneth Rapoza, CPA Industry Analyst Wall Street has its eyes on the global solar industry as China's Xinjiang province is increasingly in the spotlight...

By Kenneth Rapoza, CPA Industry Analyst Score one for the local pharmaceutical industry. FDA's essential medicine and critical inputs list gives domestic producers a a...

By Charles Benoit, CPA Trade Counsel By the end of 2020, thousands of Chinese electric cars will have descended onto American streets. Everyone who buys...

By Kenneth Rapoza, CPA Industry Analyst Why are we dependent on China's pig population for a critical animal source material used in making heparin? Bovine...

By Kenneth Rapoza, CPA Industry Analyst Deputy National Security Advisor Matt Pottinger explained during a conference in London recently how China's United Front is one...

By Kenneth Rapoza, CPA Industry Analyst A court puts a stop to tariffs on double-side solar panels. And a WSJ article singles out solar as...

By Kenneth Rapoza, CPA Industry Analyst The University of Kentucky health plan banned an imported drug this week coming from India and Portugal. They've highlighted...